Liver transplantation: where we are and where we are heading

Area of Science:

• Transplantation immunology
• Hepatobiliary surgery

Background:

• Liver transplantation outcomes are excellent but limited by organ availability.
• Donors after cardiac death (DCD) offer a potential solution but increase biliary complication risks, including ischemic cholangiopathy.
• Immunosuppressive drug toxicity poses significant morbidity challenges in transplant recipients.

Purpose of the Study:

• To review current clinical protocols for inducing immune tolerance in transplantation.
• To discuss strategies for mitigating complications associated with DCD liver transplantation.
• To highlight the future of transplantation research through interdisciplinary collaboration.

Main Methods:

• Literature review of current tolerance induction protocols.
• Analysis of complication rates in DCD liver transplants.
• Discussion of collaborative research models in transplantation.

Main Results:

• DCD liver transplantation is associated with a high incidence of biliary complications, notably ischemic cholangiopathy, often necessitating retransplantation.
• Induction of immune tolerance remains a key area of research to reduce long-term immunosuppression-related morbidity.
• Interdisciplinary collaboration, exemplified by Stanford's Institute for Immunity, Transplantation and Infection, is crucial for advancing transplantation science.

Conclusions:

• Addressing organ shortages through DCD and advancing immune tolerance are critical for improving liver transplant success.
• Minimizing ischemic cholangiopathy and immunosuppression-related morbidity are paramount challenges.
• Future progress in transplantation hinges on integrated efforts between basic scientists and clinical researchers.